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Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
T-brain-1 (TBR1) is a brain-specific T-box transcription factor. In 1995, Tbr1 was first
identified from a subtractive hybridization that compared mouse embryonic and adult
telencephalons. Previous studies of Tbr1−/− mice have indicated critical roles for TBR1
in the development of the cerebral cortex, amygdala, and olfactory bulb. Neuronal
migration and axonal projection are two important developmental features controlled by
TBR1. Recently, recurrent de novo disruptive mutations in the TBR1 gene have been
found in patients with autism spectrum disorders (ASDs). Human genetic studies have
identified TBR1 as a high-confidence risk factor for ASDs. Because only one allele of
the TBR1 gene is mutated in these patients, Tbr1+/− mice serve as a good genetic
mouse model to explore the mechanism by which de novo TBR1 mutation leads to
ASDs. Although neuronal migration and axonal projection defects of cerebral cortex
are the most prominent phenotypes in Tbr1−/− mice, these features are not found
in Tbr1+/− mice. Instead, inter- and intra-amygdalar axonal projections and NMDAR
expression and activity in amygdala are particularly susceptible to Tbr1 haploinsufficiency.
The studies indicated that both abnormal brain wiring (abnormal amygdalar connections)
and excitation/inhibition imbalance (NMDAR hypoactivity), two prominent models for ASD
etiology, are present in Tbr1+/− mice. Moreover, calcium/calmodulin-dependent serine
protein kinase (CASK) was found to interact with TBR1. The CASK–TBR1 complex had
been shown to directly bind the promoter of the Grin2b gene, which is also known as
Nmdar2b, and upregulate Grin2b expression. This molecular function of TBR1 provides
an explanation for NMDAR hypoactivity in Tbr1+/− mice. In addition to Grin2b, cell
adhesion molecules—including Ntng1, Cdh8, and Cntn2—are also regulated by TBR1
to control axonal projections of amygdala. Taken together, the studies of Tbr1 provide an
integrated picture of ASD etiology at the cellular and circuit levels.
Keywords: amygdala, axonal projection, autism, cerebral cortex, intellectual disability, neural circuit,
neurodevelopmental disorders, TBR1
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INTRODUCTION
Autism spectrum disorders (ASDs) are heterogeneous and highly
heritable neuropsychiatric disorders. Hundreds of genes with de
novo copy-number variations or de novo point mutations have
been identified in thousands of patients with ASDs (Gilman
et al., 2011; Neale et al., 2012; O’roak et al., 2012a,b; De Rubeis
et al., 2014; Iossifov et al., 2014). Although this variety of ASD-
associated genes reflects the high heterogeneity of ASDs, ∼26
high-confidence risk genes for ASDs have been summarized
from large scale whole-exome sequencing (O’roak et al., 2012a;
De Rubeis et al., 2014; Table 1). Among these high-confidence
risk genes, 11 encode either transcription factors or chromatin
remodeling factors, indicating that the dysregulation of gene
expression is a common pathogenic mechanism for ASDs
(Table 1). To date, T-BRAIN-1 (TBR-1) is the best studied
transcription regulator among the high-confidence risk genes for
ASDs. In this review, we summarize the physiological functions
of TBR1 and the currently understood mechanisms by which
TBR1 mutations cause ASDs. Based on the data accumulated
from the mouse model, we suggest that abnormal brain wiring
and reduced neuronal activity in the amygdala are the primary
causes for TBR1-dependent ASDs.
TABLE 1 | High-confidence risk factors for ASDs.
Gene symbol Gene Name Molecular function References
ADNP Activity-dependent neuroprotector homeobox Transcription regulator De Rubeis et al., 2014; SFARI
ANK2 Ankyrin 2, neuronal Cytoskeleton interactor De Rubeis et al., 2014; SFARI
ARID1B AT rich interactive domain 1B (SWI1-like) Transcription regulator De Rubeis et al., 2014; SFARI
ASH1L Ash1 (absent, small, or homeotic)-like (Drosophila) Transcription regulator De Rubeis et al., 2014; SFARI
ASXL3 Additional sex combs like transcriptional regulator 3 Transcription regulator De Rubeis et al., 2014; SFARI
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) Transcription regulator De Rubeis et al., 2014
CACNA2D3 Calcium channel, voltage-dependent, alpha 2/delta subunit 3 Ion channel De Rubeis et al., 2014
CHD8 Chromodomain helicase DNA binding protein 8 Transcription regulator De Rubeis et al., 2014; O’roak et al., 2012a; SFARI
CTTNBP2 Cortactin binding protein 2 Cytoskeleton interactor De Rubeis et al., 2014
CUL3 Cullin 3 Protein degradation De Rubeis et al., 2014
DYRK1A Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A Signaling De Rubeis et al., 2014; O’roak et al., 2012a; SFARI
GABRB3 Gamma-aminobutyric acid (GABA) A receptor, beta 3 Ion channel De Rubeis et al., 2014
GRIN2B Glutamate receptor, ionotropic, N-methyl D-aspartate 2B Ion channel De Rubeis et al., 2014; O’roak et al., 2012a; SFARI
KATNAL2 Katanin p60 subunit A-like 2 Cytoskeleton interactor De Rubeis et al., 2014
MIB1 Mindbomb E3 ubiquitin protein ligase 1 Protein degradation De Rubeis et al., 2014
MLL3 Lysine (K)-specific methyltransferase 2C Transcription regulator De Rubeis et al., 2014
POGZ Pogo transposable element with ZNF domain Enzyme De Rubeis et al., 2014; SFARI
PTEN Phosphatase and tensin homolog Phosphatase De Rubeis et al., 2014; O’roak et al., 2012a; SFARI
RELN Reelin Signaling De Rubeis et al., 2014
SCN2A Sodium channel, voltage-gated, type II, alpha subunit Ion channel De Rubeis et al., 2014; SFARI
SETD5 SET domain containing 5 Transcription regulator De Rubeis et al., 2014; SFARI
SHANK3 SH3 and multiple ankyrin repeat domains 3 Postsynaptic adaptor SFARI
SUV420H1 Suppressor of variegation 4–20 homolog 1 (Drosophila) Transcription regulator De Rubeis et al., 2014; SFARI
SYNGAP1 Synaptic Ras GTPase activating protein 1 Signaling De Rubeis et al., 2014; SFARI
TBL1XR1 Transducin (beta)-like 1 X-linked receptor 1 Transcription regulator O’roak et al., 2012a
TBR1 T-box, brain, 1 Transcription regulator De Rubeis et al., 2014; O’roak et al., 2012a; SFARI
IDENTIFICATION OF TBR1 IN THE
REGULATION OF BRAIN DEVELOPMENT
TBR1 contains a T-box DNA binding domain (Figure 1) and
belongs to the T-box transcription factor family (Papaioannou,
2014). Twenty years ago, Dr. John Rubenstein’s laboratory first
identified Tbr1 from a subtractive hybridization screen using
cDNA libraries made from mouse embryonic day 14.5 (E14.5)
and adult telencephalons (Bulfone et al., 1995). Tbr1 mRNA
levels were approximately 10-fold higher in E14.5 telencephalons
than in adult telencephalons (Bulfone et al., 1995), suggesting a
role for TBR1 in brain development. In situ hybridization and
immunofluorescence staining indicate that Tbr1 is expressed in
the postmitotic neurons of the cerebral cortex, hippocampus,
olfactory bulb and amygdala at the embryonic stages (Bulfone
et al., 1995, 1998; Remedios et al., 2007; Huang et al., 2014).
Using markers of projection neurons, including glutamate and
CaMKII, TBR1 has been found to be further restricted to
the projection neurons of the cerebral cortex, amygdala and
olfactory bulb (Bulfone et al., 1998; Hevner et al., 2001; Huang
et al., 2014). In the cerebral cortex, layer 6 neurons express the
highest levels of TBR1. Projection neurons in the remaining
layers also express TBR1, though the expression levels are lower
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FIGURE 1 | Schematic domain structure of TBR1 and identified mutations in patients with ASDs. The T-box DNA binding domain extends from amino acid
(aa) residue 203–397. The predicted aa residues for DNA binding and dimerization based on the T-box structure of Brachyury (T protein) are also indicated and labeled
with red and green strips in the T-box. The positions of de novo mutations are labeled with red triangles; the positions of rare inherited mutations are labeled with blue
triangles. The functions of the residues in the T-box are predicted based on comparison with the Brachury T-box (pfam00907: T-box, http://www.ncbi.nlm.nih.gov/
Structure/cdd/cddsrv.cgi?uid=250216).
(Hevner et al., 2001). In the amygdala, TBR1 is only expressed
in the projection neurons of the lateral and basal amygdala
(Huang et al., 2014). These studies clearly show that TBR1 is
a projection neuron-specific T-box factor highly enriched in
embryonic telencephalons.
Dr. John Rubenstein and colleagues generated Tbr1−/− mice
to investigate the physiological function of Tbr1 (Bulfone et al.,
1998; Hevner et al., 2001). A homozygous deficiency of Tbr1
results in neonatal lethality within 1–2 days after birth, indicating
that Tbr1 is essential for survival. Most projection neurons in
the olfactory bulb, including mitral and tufted cells, and axonal
output to the lateral olfactory tract are lost in Tbr1−/− mice
(Bulfone et al., 1998). In the cerebral cortex, the inside-out
pattern of neuronal migration is completely disrupted, as the six-
layer laminar structure of the cortex is disorganized. Moreover,
the contralateral axonal projections of the cerebral cortex and
both corticothalamic and thalamocortical axonal projections are
also defective, since they end mid-way to their final destinations
in Tbr1−/− mice (Hevner et al., 2001). TBR1 is also required
for neuronal migration in the amygdala. A portion of the dorsal
pallium that migrates from the caudal telencephalon pole toward
the rostral telencephalon forms the basal and lateral amygdala.
In Tbr1−/− mice, this caudal-to-rostral migration is disrupted
and thus impairs amygdala development (Remedios et al., 2007).
Although TBR1 is also expressed in the hippocampus, its
importance in hippocampus development and function remains
unclear.
Based on the studies using Tbr1−/− mice, it is clear that TBR1
is critical for development of projection neurons in the cerebral
cortex, olfactory bulb and amygdala.
TBR1 DOWNSTREAM TARGET GENES
Target genes of the TBR1 transcription factor were first identified
by searching a database using the target sequence of the T-
box DNA binding domain (Hsueh et al., 2000; Wang et al.,
2004a,c). Because members of the T-box protein family share
a DNA binding sequence, this method cannot ensure that the
target genes are specific for TBR1. Because TBR1 is neuron-
specific, neuronal expression is the first criterion to further
screen the TBR1 target genes identified from sequence analysis.
Results of an electrophoretic mobility shift assay, chromatin
immunoprecipitation and a luciferase reporter assay have shown
that TBR1 directly binds to the promoters and regulates the
promoter activity of Grin2b (Glutamate receptor, ionotropic, N-
methyl-aspartate 2b, also known as Nmdar2b) and Reln (Reelin)
(Hsueh et al., 2000; Wang et al., 2004a,c). Changes in RELN and
NMDAR2B protein levels have also been confirmed in Tbr1−/−
mice (Hevner et al., 2001; Wang et al., 2004c). Because Reln
encodes an extracellular protein that is critical for neuronal
migration (Martinez-Cerdeno and Noctor, 2014; Ohshima, 2014;
Sekine et al., 2014), regulation of Reln expression by TBR1 could
explain the migration phenotype in Tbr1−/− mice. Regulation
of Grin2b expression by TBR1 is critical for neuronal activation,
which we discuss further in a later section.
Both our and Dr. Robert Hevner’s laboratories independently
applied microarray analyses to identify TBR1 downstream genes.
Using E14.5 and P0.5 mouse brains, Dr. Hevner’s laboratory
focused on the arealization and lamination of the cerebral cortex
(Bedogni et al., 2010). Tbr1 exhibits a high rostral and low caudal
expression pattern in the cortex (Bulfone et al., 1995). At both
E14.5 and P0.5, a Tbr1 deletion noticeably alters the expression
of regional markers. In general, rostral genes are downregulated
in Tbr1−/− brains, while caudal genes are upregulated. For
cortical layer markers, most markers of layer 6, subplate and
Cajal–Retzius cells exhibit noticeably reduced expression levels
in Tbr1−/− brains. The majority of layer 2–5 markers are
upregulated (Bedogni et al., 2010). The markers of lamination
and arealization whose expression levels are altered in Tbr1−/−
brains are listed in Table 2. These studies indicate that TBR1 is
critical for controlling the neuronal specification of the cerebral
cortex.
In our laboratory, we have identified more than 124 genes
that are regulated by TBR1 at E16.5 (Huang et al., 2014;
Chuang et al., 2015). The 16 region- or layer-specific genes
presented in work by Bedogni et al. (2010) from Dr. Hevner’s
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TABLE 2 | Tbr1 deletion alters expression of genes with layer- or region-specific distribution in the cerebral cortex.
Gene symbol* Gene name Layer Region
Bhlhb5 (BHLHE22) Basic helix-loop-helix family, member e22 L5 Caudomedial
Calb2 Calbindin 2 Cajal–Retzius All
Cdh8* Cadherin 8, type 2 L5 Rostral + caudal
Cdh9 Cadherin 9, type 2 (T1-cadherin) L6 Rostral
Cntn3 Contactin 3 (plasmacytoma associated) L5 Caudal
Cntn6* Contactin 6 L5 SCPN Caudal
Cplx3 Complexin 3 Cajal–Retzius All
Crim1* Cysteine rich transmembrane BMP regulator 1 (chordin-like) L5 corticospinal motor neuron All
Crym Crystallin, mu L5 corticospinal motor neuron Caudal
Ctgf* Connective tissue growth factor Subplate All
Ctip2 (Bcl11b) B-cell CLL/lymphoma 11B (zinc finger protein) L5 SCPN All
Cux1 Cut-like homeobox 1 L2–4 All
Cux2 Cut-like homeobox 2 L2–4 All
Dkk3 Dickkopf WNT signaling pathway inhibitor 3 CPN Caudomedial
Drd1a* Dopamine receptor D1 L6 All
Dtx4 Deltex 4, E3 ubiquitin ligase L2–4 All
Etv1 (Er81) Ets variant 1 L5 All
Fezf2 FEZ family zinc finger 2 L5 SCPN All
Flrt3* Fibronectin leucine rich transmembrane protein 3 L2–3 Caudal
Foxp1 Forkhead box P1 L5 All
Foxp2 Forkhead box P2 L6 All
Inhba Inhibin, beta A L2–4, CPN All
Lhx5 LIM homeobox 5 Cajal–Retzius All
Limch1 LIM and calponin homology domains 1 L2–3, CPN All
Mdga1 MAM domain containing glycosylphosphatidylinositol anchor 1 L2–3 Caudal
Mef2c Myocyte enhancer factor 2C L2–3 All
Nefm* Neurofilament, medium polypeptide L2–3 Caudal
Nfe2l3 Nuclear factor, erythroid 2-like 3 L6 All
Ngfr Nerve growth factor receptor L6 Caudal
Nhlh2* Nescient helix loop helix 2 Cajal–Retzius All
Npy Neuropeptide Y L6 All
Nr4a2 (Nurr1)* Nuclear receptor subfamily 4, group A, member 2 L6 Caudal
Nr4a3 Nuclear receptor subfamily 4, group A, member 3 L6 Caudal
Nrgn* Neurogranin L2–4 All
Nxph4 Neurexophilin 4 Subplate All
Oma1 OMA1 zinc metallopeptidase L5 SCPN All
Pcdh11x Protocadherin 11 X-linked L2–4 All
Pcdh19 Protocadherin 19 L5 All
Pcdh20 Protocadherin 20 L2–4 Rostral
Pcdh8 Protocadherin 8 L2–3 Caudal
Pcp4 Purkinje cell protein 4 L5 All
Pou3f2 (Brn-2) POU class 3 homeobox 2 L2–4 All
Pou3f3 (Brn-1) POU class 3 homeobox 3 L2–4 All
Ppp1r1b* Protein phosphatase 1, regulatory (inhibitor) subunit 1B L6 Rostral
Ptn Pleiotrophin CPN All
Ptprz1 Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 L2–3 Caudal
Pvrl3 Poliovirus receptor-related 3 L2–3, CPN Caudomedial
Reln* Reelin Cajal–Retzius All
Rgs8 Regulator of G-protein signaling 8 L2–3 All
Rorb* RAR-related orphan receptor B L4 Rostral
S100a10 S100 calcium binding protein A10 L5 corticospinal motor neuron All
(Continued)
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TABLE 2 | Continued
Gene symbol* Gene name Layer Region
Satb2 SATB homeobox 2 CPN All
Sorl1 Sortilin-related receptor, L(DLR class) A repeats containing L2–3 All
Sox5* SRY (sex determining region Y)-box 5 L6 All
Tle1 Transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) L2–3 All
Tle4* Transducin-like enhancer of split 4 L6 All
Tox Thymocyte selection-associated high mobility group box L5 Rostromedial
Trp73 Tumor protein p73 Cajal–Retzius All
Unc5c Unc-5 homolog C (C. elegans) L4 All
Unc5d (Svet1) Unc-5 homolog D (C. elegans) L2–4 All
Wnt7b* Wingless-type MMTV integration site family, member 7B L6 All
Wscd1 WSC domain containing 1 L6 Rostral
Zfpm2 (FOG2) Zinc finger protein, FOG family member 2 L6 All
*Genes also identified in our microarray analysis (Huang et al., 2014). CPN, callosal projection neurons; SCPN, subcerebral projection neurons.
laboratory are also included in our gene list (Table 2). Moreover,
based on a literature search and the database of the Simons
Foundation Autism Research Initiative (https://gene.sfari.org/
autdb/Welcome.do), 23 ASD-associated genes and a dyslexia
causative gene, Kiaa0319, have also been found to be regulated
by TBR1. Changes in the expression of these ASD- and dyslexia-
associated genes (Table 3) provide support for the influence
of TBR1 in ASDs. Tbr1 might act as master gene controlling
the expression of a panel of ASD-associated genes and thus
influence neural development and function (Chuang et al.,
2015).
Moreover, the expression levels of 15 transcriptional
regulators are reduced, while those of three transcription factors
are upregulated in Tbr1−/− brains compared with wild-type
littermates (Table 4). These changes suggest that, in addition
to directly regulating gene expression, TBR1 also controls
transcriptional networks to influence neuronal development.
Indeed, evidence has indicated that TBR1 directly binds to the
locus of Fezf2, a layer 5-specific transcription factor, and represses
Fezf2 expression in layer 6 to specify the corticothalamal
projections of layer 6 neurons (Han et al., 2011; McKenna et al.,
2011). The second transcriptional regulator directly controlled by
TBR1 is autistic susceptibility gene2 (Auts2). TBR1 binds to the
region around the Auts2 transcriptional start site and activates
expression of the Auts2 gene (Bedogni et al., 2010). AUTS2 is
part of polycomb repressive complex I (PRCI) that catalyzes the
monoubiquitination of histone H2A and epigenetically represses
gene expression, particularly during the developmental stage
(de Napoles et al., 2004; Wang et al., 2004b). In contrast to the
canonical role of PRCI in gene repression, the PRCI–AUST2
complex activates neuronal gene expression by recruiting casein
kinase 2 and p300 to chromatin (Gao et al., 2014). The activation
of Auts2 expression by TBR1 supports the influence of TBR1 on
global gene expression in neurons.
In addition to using a transcriptional cascade to indirectly
control gene expression, TBR1 may also alter the relative
number of projection neurons and interneurons in the brain
and influence the total expression levels of certain genes, such as
Gad1, which encodes glutamate decarboxylase 1 (GAD67)—an
essential gene of GABAergic neurons. In Tbr1 deletion mice,
the expression of Gad1 is noticeably upregulated (Chuang et al.,
2015). Because Tbr1 is specifically expressed in glutamatergic
projection neurons, it is possible to speculate that increasedGad1
expression is indirectly linked to a reduction in the population of
glutamatergic neurons.
Consistent with the function of TBR1 in the regulation of
axonal projection, TBR1 also regulates eight membrane proteins
(CNTN2, CDH8, GPC6, CD44, FLRT3, CNTN6, NTNG1, and
KIAA0319) that are involved in cell adhesion; although it is still
unclear whether these genes are directly or indirectly regulated
by TBR1 (Chuang et al., 2015). Interestingly, seven of these eight
membrane proteins are upregulated in Tbr1−/− brains (Table 5).
Because these genes control cell adhesion and axonal growth,
the impairment of axonal projection in Tbr1 deficient neurons
is likely due to imbalanced cell–cell and cell–matrix interactions.
Alteration of the strength of these interactions may preclude
neurite growth and extension (Chuang et al., 2015).
In conclusion, TBR1 controls the expression of a series
of genes that regulate cell-cell adhesion, axonal growth,
neurotransmission and gene expression.
TBR1 INTERACTING PROTEINS
To date, only two proteins, CASK and FOXP2, have been
identified as interacting partners with TBR1. Both CASK and
FOXP2 are associated with ASDs (Samuels et al., 2007; O’roak
et al., 2011). TBR1 was identified as a binding partner for
CASK from a yeast two-hybrid screen using the guanylate kinase
domain of CASK as bait (Hsueh et al., 2000). The C-terminal
region of TBR1 is required for the interaction with CASK (Hsueh
et al., 2000). CASK—a multidomain adaptor protein—is widely
distributed in various subcellular compartments and interacts
with more than two dozen cellular proteins (Hsueh, 2006). The
interaction with CASK increases the transcriptional activity of
TBR1 (Hsueh et al., 2000) by recruiting a nucleosome assembly
protein CINAP (CASK interacting nucleosome assembly protein,
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TABLE 3 | TBR1 influences the expression (upregulation or downregulation) of genes associated with autism or dyslexia.
Gene symbol Gene name Molecular function Tbr1−/− vs. WT Disease
Cd44 CD44 molecule (Indian blood group) Cell adhesion Up Autism
Cdh8 Cadherin 8, type 2 Cell adhesion Up Autism
Cntn6 Contactin 6 Cell adhesion Up Autism
Gpc6 Glypican 6 Cell adhesion Up Autism
Ntng1 Netrin G1 Cell adhesion Up Autism
Kiaa0319 Hypothetical protein D130043K22 Cell adhesion Up Dyslexia
Nefl Neurofilament, light polypeptide Cytoskeleton Up Autism
Gpd2 Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) Enzyme Up Autism
Drd1 Dopamine receptor D1A Neurotransmission Down Autism
Gad1 Glutamate decarboxylase 1 (brain, 67 kDa) Neurotransmission Up Autism
Grin2b Glutamate receptor, ionotropic, N-methyl D-aspartate 2B Neurotransmission Down Autism
Baiap2 BAI1-associated protein 2 Signaling Down Autism
Lasp1 LIM and SH3 protein 1 Signaling Down Autism
Lypd6 LY6/PLAUR domain containing 6 Signaling Down Autism
Ppp1r1b Protein phosphatase 1, regulatory (inhibitor) subunit 1B Signaling Down Autism
Ptprk Protein tyrosine phosphatase, receptor type, K Signaling Down Autism
Reln Reelin Signaling Down Autism
Auts2 Autism susceptibility candidate 2 Transcription factor Down Autism
Nfia Nuclear factor I/A Transcription factor Down Autism
Nr4a2 Nuclear receptor subfamily 4, group A, member 2 Transcription factor Down Autism
Sox5 SRY (sex determining region Y)-box 5 Transcription factor Down Autism
Slc4a10 Solute carrier family 4, sodium bicarbonate transporter, member 10 Transporter Up Autism
Stxbp6 Syntaxin binding protein 6 (amisyn) Vesicle trafficking Up Autism
Sv2b Synaptic vesicle glycoprotein 2B Vesicle trafficking Down Autism
also known as testis specific protein Y-encoded like 2, TSPYL2) to
the promoter region containing the T-box DNA binding motif
(Wang et al., 2004a). CINAP also interacts with the guanylate
kinase domain of CASK. However, it does not compete with
TBR1 for CASK binding. Instead, TBR1, CASK and CINAP
form a tripartite complex to regulate Grin2b expression (Wang
et al., 2004a,c). CASK is well-known as a causative gene in X-
linked mental retardation (Najm et al., 2008). The interaction of
CASK and TBR1 and the consequent effect on the regulation of
Grin2b expression and neural development has been suggested
to contribute to the phenotype of patients with CASK mutations
(Hsueh, 2009). It can also be speculated thatGrin2b expression, as
controlled by the TBR1–CASK complex, might also be involved
in ASDs due to TBR1 or CASK mutations.
FOXP2 is a critical transcription factor that controls speech
(Lai et al., 2001; Enard et al., 2002) and is also associated with
ASDs (Gong et al., 2004; Li et al., 2005). In contrast to the
interaction between CASK and TBR1, the interaction between
TBR1 and FOXP2 is less clear. Research suggests that both
the T-box and C-terminal regions of TBR1 are involved in the
interaction with FOXP2 (Deriziotis et al., 2014). For FOXP2,
both its N- and C-terminal regions contribute to the interaction
between FOXP2 and TBR1 (Deriziotis et al., 2014). Although it
has been speculated that the interaction of FOXP2 and TBR1
is likely relevant to the verbal deficits in ASD patients, the
molecular function of the TBR1-FOXP2 interaction is unclear.
Furthermore, FOXP2 and TBR1 are only coexpressed in layer 6
of the cerebral cortex and not in other layers of the cerebral cortex
and amygdala. Thus, the interaction with FOXP2 can only partly
account for the function of TBR1.
TBR1, its binding partners CASK and FOXP2 and its direct
downstream target GRIN2B, are all associated with ASDs,
reinforcing the role of TBR1 in ASDs.
TBR1 MUTATIONS ASSOCIATE WITH
NEUROLOGICAL DISORDERS
Genetic analyses of patients have identified TBR1 as a high-
confidence risk factor for ASDs (https://gene.sfari.org/autdb/
GSGeneList.do?c=1). Identified mutations in TBR1 genes are
summarized in Figure 1. Both de novo and inherited mutations
in TBR1 have been found in patients with ASDs (Figure 1).
Two of the mutations, p.A136PfsX80 and p.S351X, result in
early termination and generate truncated proteins that lack a
functional DNA-binding T-box domain (O’roak et al., 2012a,b;
De Rubeis et al., 2014). These two truncated mutants can no
longer function in transcription or in interactions with CASK
and FOXP2. The remaining three de novomutations are p.K228E,
p.W271C, and p.N374H (Figure 1). Based on simulations with
the T-box DNA binding domain of Brachury (http://www.ncbi.
nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=250216), the K228
residue is predicted to directly contribute to DNA binding
(Figure 1). Thus, the p.K228E mutation is expected to disrupt
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TABLE 4 | Deletion of Tbr1 influences the expression of a panel of transcription factors in neurons.
Gene Symbol Tbr1−/− vs. WT Gene name
Bcl6 0.3623 B-cell leukemia/lymphoma 6
Nfe2l3 0.4017 Nuclear factor, erythroid derived 2, like 3
Nhlh2 0.4219 Nescient helix loop helix 2
Sox5 0.4875 BB018032 RIKEN full-length enriched, adult male testis (DH10B) Mus musculus cDNA clone 4930572C18 3′ similar to
AJ010604 Mus musculus mRNA for transcription factor L-Sox5, mRNA sequence.
Nr4a2 0.5179 BB703394 RIKEN full-length enriched, in vitro fertilized eggs Mus musculus cDNA clone 7420451N07 3′, mRNA sequence.
Rorb 0.529 RAR-related orphan receptor beta
Tp73 0.5355 Transformation related protein 73
Btbd11 0.5719 BTB (POZ) domain containing 11
Tle4 0.5821 Transducin-like enhancer of split 4, homolog of Drosophila E(spl)
Rbm14 0.59 RNA binding motif protein 14
Foxf2 0.5983 Forkhead box F2
Tfap2c 0.6348 Transcription factor AP-2, gamma
Zswim4 0.639 Zinc finger, SWIM domain containing 4
Nfia 0.643 RIKEN cDNA 9430022M17 gene
Neurod6 0.6644 Neurogenic differentiation 6
Runx1t1 1.5064 CBFA2T1 identified gene homolog (human)
Ascl1 1.6328 Achaete–scute complex homolog-like 1 (Drosophila)
Pou3f1 1.6528 POU domain, class 3, transcription factor 1
TABLE 5 | Tbr1 deletion mainly upregulates expression of cell adhesion
molecules in neurons.
Gene symbol Tbr1−/− vs. WT Gene name
Cdh8 1.5013 Cadherin 8
Gpc6 1.5874 Glypican 6
Cd44 1.7384 CD44 antigen
Flrt3 1.8118 Fibronectin leucine rich transmembrane
protein 3
Cntn6 2.0967 Contactin 6
Ntng1 2.3218 Netrin G1
Kiaa0319 2.8456 Hypothetical protein D130043K22
Cntn2 0.6331 Contactin 2
the DNA binding ability of TBR1. The residues W271 and
N374 are adjacent to the DNA binding residues (Figure 1).
Thus, the p.W271C and p.N374H mutations could alter protein
conformation and indirectly influence DNA binding. The
p.V356M inherited mutation is localized in the T-box, but it is
relatively far from the DNA binding and dimerization motifs.
The remaining inherited mutations, including p.E31Q, p.P38T,
p.Q178E, p.Q418R, p.V437L, and p.P542R, are localized to the
N- and C-terminal regions and are not known to influence DNA
binding. The impact of these inherited mutations is unclear.
To date, only two studies have analyzed the effects of
these ASD mutations on TBR1 function. We contributed to
the first functional study, which examined axonal growth in
the amygdalar neurons of the TBR1 N374H mutant (Huang
et al., 2014). An experiment comparing Tbr1+/− and wild-type
amygdalar neurons showed that the deletion of one Tbr1 gene
results in multiple and shorter axons in amygdalar neurons
(Huang et al., 2014). The reintroduction of wild-type Tbr1 into
Tbr1+/− amygdalar neurons effectively promotes axon growth
and reduces the percentage of neurons carrying multiple axons to
the levels seen in wild-type neurons. However, theN374Hmutant
fails to rescue the axonal defects of Tbr1+/− amygdalar neurons,
suggesting that the p.N374H mutation identified in patients with
ASD results in a loss of function (Huang et al., 2014).
The second study focused on the effect of ASD mutations on
the subcellular distribution, transcriptional activity, dimerization
and protein-protein interaction of TBR1 using heterologous
HEK293 cells as a model (Deriziotis et al., 2014). De
novo mutations, including p.K228E and p.N374H, change the
subcellular distribution of TBR1 in HEK293 cells. The mutant
proteins tend to form large aggregates in the nuclei. The impact
of these two mutations on the transcriptional activity of TBR1
is unclear because the luciferase reporter assay did not show a
difference between the wild-type TBR1 and K228E and N374H
mutants. However, similar to the truncated mutants, the K228E
and N374H mutants no longer interact with FOXP2, which
is consistent with the observation that the T-box domain is
also involved in FOXP2 interactions, as described above. The
mechanisms by which rare inherited mutations impair the
function of TBR1 remain largely unclear, except for the p.Q418R
mutation, which is known to reduce the interaction between
TBR1 and FOXP2. Because TBR1 is a projection neuron-specific
transcription factor, the relevance of the interaction between
TBR1 and FOXP2 must be investigated in neurons instead of
HEK293 cells.
In addition to ASDs, TBR1 is also associated with intellectual
disability. The TBR1 locus is at chromosome 2q24.2. Both a
microdeletion of the chromosome region that contains 2q24.2
and de novo mutations of the TBR1 gene have been found in
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patients with intellectual disabilities (Traylor et al., 2012; Burrage
et al., 2013; Hamdan et al., 2014; Palumbo et al., 2014). Moreover,
the expression levels of TBR1 are increased in patients that suffer
from schizophrenia (Molnar et al., 2003). Taken together, TBR1
is closely associated with ASDs, schizophrenia and intellectual
disability.
Tbr1 HAPLOINSUFFICIENCY RESULTS IN
NEURONAL DEFECTS
In ASD patients, only one of the two TBR1 alleles is mutated
(Neale et al., 2012; O’roak et al., 2012a,b; De Rubeis et al., 2014;
Deriziotis et al., 2014). Several possibilities may explain the effect
of TBR1 heterozygosity on brain function: haploinsufficiency or
a dominant negative or gain-of-function effect of the mutated
allele. Because two of the de novo mutations of the TBR1
gene, p.A136PfsX80, and p.S351X, result in early termination
and generate truncated proteins that lack a full length T-box
DNA binding domain and dimerization domain (Figure 1), the
mutants are not expected to exert a dominant negative effect on
the activity of TBR1 based on the known molecular function of
TBR1. Instead, the defects are likely caused by haploinsufficiency.
Tbr1+/− neurons are characterized by shorter andmultiple axons
(Huang et al., 2014), indicating that loss of a copy of theTbr1 gene
results in abnormal neuronal differentiation. Thus, TBR1 deficits
in patients are likely due to haploinsufficiency.
Tbr1+/− MICE SERVE AS A MOUSE
MODEL FOR ASDS
Because only one of two TBR1 alleles is mutated in patients
with ASDs and Tbr1 heterozygosity does not influence survival
and the general health of mice, Tbr1+/− mice serve as a good
animal model to elucidate the role of Tbr1 in ASDs. The core
symptoms of patients with ASDs are both verbal and non-
verbal communication defects, impaired social interaction and
cognitive inflexibility. ASDs are also frequently associated with
learning disability. A series of behavior paradigms have been
applied to characterize the behavioral defects of Tbr1 (Table 6).
Compared with wild-type littermates, the locomotor and
TABLE 6 | Tbr1 haploinsufficiency results in autism-like behaviors in mice.
Behavior paradigm Assay for Phenotype in Tbr1+/−
mice
Conditioned taste aversion Learning and memory Learning defect
Auditory fear conditioning Learning and memory Learning defect
T-maze test Reverse learning Cognition inflexibility
Two-choice digging task Reverse learning Cognition inflexibility
Three-chamber test Social interaction Poor social interaction
Reciprocal social
interactions
Social interaction Poor social interaction
Social transmission of food
preference
Social interaction Poor social interaction
Ultrasonic vocalizations Communication Poor communication
exploratory activities, the level of anxiety and the hippocampus-
dependent memory of Tbr1+/− mice are normal (Huang et al.,
2014). However, the amygdala-dependent behaviors of Tbr1+/−
mice are noticeably affected. Conditioned taste aversion and
auditory fear conditioning—two amygdala-dependent learning
and memory paradigms—are both impaired in Tbr1+/− mice.
Cognitive flexibility, as examined by appetitive-motivated T-
maze and two-choice digging tests, is also noticeably reduced
in Tbr1+/− mice. The three-chamber test, reciprocal social
interactions and social transmission of food preferences have also
been applied to characterize the social interactions of Tbr1+/−
mice. These paradigms all indicate that the social interactions
of Tbr1+/− mice are impaired. Moreover, the frequency of
ultrasonic vocalization is significantly lower in isolated Tbr1+/−
pups. Thus, these behavioral analyses strongly support that
Tbr1+/− mice exhibit autism-like behaviors (Huang et al., 2014).
DEFECTS IN AMYGDALAR CIRCUITS AND
ACTIVATION ARE CRITICAL FOR ASDS
CAUSED BY Tbr1 DEFICIENCY
When Tbr1 is completely deleted frommice, the most prominent
phenotypes are observed in the neuronal migration and axonal
projection of the embryonic cerebral cortex (Bulfone et al., 1998;
Hevner et al., 2001). However, none of these defects are found
in the Tbr1+/− brain (Huang et al., 2014). Cortical lamination,
contralateral cortical projection, corticothalamal projection and
the size of the cerebral cortex of Tbr1+/− brains are comparable
to those of wild-type brains (Huang et al., 2014). Unexpectedly,
the posterior part of the anterior commissure is either missing
or dramatically reduced in Tbr1+/− mice (Huang et al., 2014).
This defect is 100% penetrant in all Tbr1+/− mice. Thus, the
posterior part of the anterior commissure is the structure most
sensitive to Tbr1 haploinsufficiency. Consequently, defects of the
posterior part of the anterior commissure are more relevant to
the pathogenesis of TBR1-dependent ASDs.
The posterior part of the anterior commissure serves
to connect the contralateral amygdalae (interamygdalar
projections). The amygdala contains three major nuclei,
namely the lateral, basal and central amygdala (Figure 2).
Interamygdalar projections emerge from the lateral and basal
amygdala. These two nuclei also project to the ipsilateral central
amygdala (intraamygdalar projections). The lateral and basal
amygdalae are the nuclei that receive inputs from the cortex,
thalamus and hippocampus. To induce a freezing response,
the lateral and basal amygdalae deliver the signals to the
central amygdala, and the central amygdala further projects
to the brainstem and hypothalamus. In addition to the central
amygdala, the lateral and basal amygdalae also project back to
the cortex, hippocampus, and thalamus, which are believed to
regulate memory and social behavior (Lee et al., 2013; Janak and
Tye, 2015). Because the amygdala is the pivotal brain structure
for social intelligence, the amygdala is an obvious target for the
etiology of TBR1-dependent ASDs.
The results of DiI tracing and retrograde red bead labeling
show that both inter- and intra-amygdalar axonal projections
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are noticeably impaired in Tbr1+/− mice (Figure 3; Huang
et al., 2014). The lateral and basal amygdala neurons are
the major target of Tbr1 haploinsufficiency. Consistent with
the axonal projection defects in the brain, Tbr1+/− amygdala
neurons possess shorter and multiple axons, which suggests that
Tbr1 haploinsufficiency results in a cell-autonomous effect that
restricts axonal extension and differentiation (Huang et al., 2014).
FIGURE 2 | Neural circuits of amygdala. The relative position of lateral,
basal and central amygdalae and the known axonal connections of amygdala
are summarized. In lateral and basal amygdalae, glutamatergic neurons
comprise the majority of cells. In contrast, GABAergic neurons are the major
population in the central amygdala. Dark red lines, afferent pathways from
cortex, thalamus and hippocampus; red lines, efferent pathways to
contralateral amygdala, cortex and hippocampus; orange lines, intraamygdalar
pathways. The central amygdala also delivers signals to the brainstem and
hypothalamus to regulate freezing and emotion responses.
To investigate how TBR1 controls axonal growth, we examined
the TBR1 downstream target genes in a gene list from our
microarray data. Specifically, we examined Cntn2, Cdh8, and
Ntng1 because these three genes encode adhesion proteins that
regulate neurite outgrowth and fasciculation (Furley et al., 1990;
Stoeckli and Landmesser, 1995; Kunz et al., 1998; Nakashiba
et al., 2002; Bekirov et al., 2008). Restoring the expression levels
of Cntn2, Cdh8, and Ntng1 in Tbr1+/− amygdalar neurons
effectively ameliorates axonal growth and differentiation in
cultures and promotes axonal projection to form the posterior
part of the anterior commissure in vivo. Thus, TBR1 controls
the expression of a panel of genes that regulate amygdalar
axonal projections. Note that although the axonal projections
of lateral and basal amygdalae are significantly impaired in
Tbr1+/− brains, the size and cell density of the lateral and basal
amygdalae do not differ between Tbr1+/− mice and wild-type
littermates. It is unclear whether Tbr1+/− amygdalar neurons
mistarget to other brain regions. More investigations are needed
to characterize this regulation in detail.
Although the significance of interamygdalar connections is
unclear, a reduction of intraamygdalar axonal projections implies
that the amygdala is functionally impaired in Tbr1+/− mice.
Indeed, neuronal activation of the amygdala is impaired in
Tbr1+/− mice (Huang et al., 2014). Two amygdala-dependent
learning/memory paradigms—conditioned taste aversion and
auditory fear conditioning—have been used to investigate
amygdalar responses. Both c-FOS and NMDAR2B protein levels
were used to monitor neuronal activation in amygdalae. These
experiments showed that the induction of both c-FOS and
NMDAR2B are either much lower or completely absent in the
lateral and basal amygdalae of Tbr1+/− mice after conditioned
taste aversion training and auditory fear conditioning (Huang
et al., 2014; Chuang et al., 2015). Thus, both axonal projection
and neuronal activation are defective in Tbr1+/− amygdalae.
Possibly due to an impairment of NMDAR induction in the
Tbr1+/− amygdala, electrophysiological recording data showed
FIGURE 3 | Tbr1 haploinsufficiency results in defects of intra- and inter-amygdalar axonal projections. (A)Wild-type mice. (B) Tbr1+/− mice. (C) Tbr1+/−
mice with D-cycloserine or clioquinol injection. The interamygdalar projection via the posterior part of the anterior commissure is significantly impaired in Tbr1+/− mice.
Intraamygdalar connections between basolateral and central amygdalae are also noticeably reduced in Tbr1+/− mice. Tbr1+/− mice are characterized by autism-like
behaviors. Increased neuronal activity in the amygdala using either D-cycloserine or clioquinol restores behavioral defects to normal levels, although axonal projection
defects are not rescued.
Frontiers in Neuroscience | www.frontiersin.org 9 November 2015 | Volume 9 | Article 406
Huang and Hsueh TBR1 haploinsufficiency in ASDs
that the NMDA/AMPA ratio is noticeably lower in the thalamic-
lateral amygdala synapses of Tbr1+/− brains compared with
those of wild-type brains (Lee et al., 2015b). Consistent with
amygdala-specific defects in Tbr1+/− mice, the hippocampal
Schaffer collateral-CA1 pyramidal synapses do not exhibit
this abnormal NMDA/AMPA ratio (Lee et al., 2015b). These
electrophysiological studies clearly demonstrate a functional
NMDAR deficiency in Tbr1+/− amygdalae.
If impairment of amygdala activation, and particularly
reduced NMDAR activity, is critical for autism-like behaviors
in Tbr1+/− mice, the activation of amygdalar neurons should
ameliorate the behavioral defects of Tbr1+/− mice. Indeed,
a bilateral local infusion of D-cycloserine (a coagonist of
NMDAR) into the amygdala clearly ameliorates the reciprocal
social interaction and conditioned taste aversion defects seen in
Tbr1+/− mice (Huang et al., 2014). D-cycloserine applied 30min
before the behavioral assay does not influence the expression of
TBR1 target genes, suggesting the behavioral effects are mediated
by an acute enhancement of NMDAR transmission. Because
administration of D-cycloserine to the amygdala is sufficient to
ameliorate the behavioral defects of Tbr1+/− mice, the etiology
of autism-like behaviors in Tbr1+/− mice very likely involves
amygdala defects (Huang et al., 2014).
In addition to local infusion, systemic administration of
D-cycloserine via an intraperitoneal injection also effectively
restores neuronal activation of the Tbr1+/− amygdala and
improves social interaction, cognitive inflexibility and associative
memory of Tbr1+/− mice (Huang et al., 2014). These results
indicate a potential therapeutic avenue for ASD patients
possessing TBR1 gene mutations. Tbr1+/− mice are not the only
mouse model to have been used to demonstrate the beneficial
effect of D-cycloserine. The behavioral deficits of Shank2−/−,
Nlgn1−/−, and Grid1−/− mice can also be ameliorated
by systemic administration of D-cycloserine. Specifically, D-
cycloserine improves social interactions in both Shank2−/− and
Grid1−/− mice in a three-chamber test (Won et al., 2012; Yadav
et al., 2012). Furthermore, D-cycloserine reduces the repetitive
grooming behavior of Nlgn1−/− mice (Blundell et al., 2010).
These three mutant mice all show NMDAR defects, which is
consistent with the idea that NMDAR deficits are critical to the
etiology of ASDs (Lee et al., 2015a). Improving NMDAR activity
can ameliorate the behavioral defects of these mutant mice.
To further support the NMDAR deficit hypothesis in ASDs,
we recently showed that by improving NMDAR activity via
the administration of clioquinol, the social defects of Tbr1+/−
mice are rescued (Lee et al., 2015b). Clioquinol is a zinc chelator
and ionophore that promotes the mobilization of zinc from
presynaptic vesicles to the postsynaptic site. The postsynaptic
elevation of zinc activates the protein tyrosine kinase SRC
and consequently enhances NMDAR activity. Systemic
administration of clioquinol noticeably improves the sociability
of the mutant mice in the three-chamber test. Consistent
with the behavioral rescue, the defective electrophysiological
responses of mutant brains are also ameliorated by clioquinol
treatment. In Tbr1+/− brains, clioquinol can restore the
reduced NMDA/AMPA ratio of the thalamic-lateral amygdala
synapses. Clioquinol treatment also shows a beneficial effect
on Shank2−/− mice. It enhances the NMDAR activity of
hippocampal Schaffer collateral-CA1 pyramidal synapses in
Shank2−/− mice (Lee et al., 2015b). Even though the molecular
mechanisms responsible for the NMDAR deficit differ between
Tbr1+/− and Shank2−/− mice, increasing NMDAR activity via
D-cycloserine or clioquinol efficiently ameliorates the behavioral
defects of these two mutant mice. These data support that an
NMDAR deficit is likely to be a common pathogenic mechanism
of ASDs. Moreover, studies using D-cycloserine and clioquinol
suggest that activation of amygdalar neurons using suitable
pharmacological treatments can ameliorate the behavioral
defects caused by Tbr1 haploinsufficiency, even though the
axonal projection defects of the Tbr1+/− amygdala cannot be
rescued in adult animals.
Tbr1 SERVES AS IMMEDIATE EARLY GENE
TO CONTROL NEURONAL ACTIVATION IN
MATURE NEURONS
Although the expression levels of Tbr1 gradually decline after
birth, the protein levels of TBR1 remain detectable in adult mouse
brains (Hsueh et al., 2000; Hong and Hsueh, 2007). Based on
the following scenario, TBR1 may also play a role in the adult
brain. TBR1 regulates Grin2b expression (Wang et al., 2004a),
and CASK phosphorylation by protein kinase A (PKA) enhances
this regulation. CASK phosphorylation increases the interaction
between TBR1 and CASK and thus upregulates Grin2b promoter
activity (Huang et al., 2010). Therefore, PKA phosphorylation
may increase the ability of TBR1 to influence Grin2b expression,
even though the expression levels of Tbr1 are lower in adult
brains.
A study of in vitro cultured neurons unexpectedly showed
that glutamate and bicuculline treatments noticeably upregulates
Tbr1 expression (Chuang et al., 2014). Two to six hours after
glutamate or bicuculline treatment, both the RNA and protein
levels of Tbr1 are obviously increased. This induction is transient.
The RNA levels of Tbr1 are decreased to basal levels 12 h
after stimulation. This feature is shared among the cortical,
hippocampal, and amygdalar neurons, although the induction
of Tbr1 expression is much less pronounced in hippocampal
neurons (Chuang et al., 2014). In addition to cultured neurons,
behavioral stimulation also changes Tbr1 expression levels in
mouse brains. When conditioned taste aversion is applied to
stimulate neuronal activation, similar to c-Fos induction, Tbr1
RNA levels in the lateral amygdala, the insular cortex and the
ventral hippocampus are also transiently increased 2 h after
training (Chuang et al., 2014). Neuronal activation also induces
Grin2b expression in vitro and in vivo, but this induction
occurs several hours after that of Tbr1. Moreover, deletion of
Tbr1 completely blocks Grin2b induction in culture (Chuang
et al., 2014). Both NMDAR and CaMKII are required to induce
Tbr1 expression (Figure 4). Thus, in addition to regulating
axonal differentiation and neuronal migration during the early
developmental stage, Tbr1 also acts as an immediate early gene in
response to synaptic stimulation in mature neurons, which might
contribute to the etiology of TBR1-related ASDs. In particular,
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FIGURE 4 | TBR1 acts as an immediate early gene to induce Grin2b
expression during neuronal activation. Both bicuculline, an antagonist of
GABAA receptors, and glutamate treatment induce Tbr1 expression. Although
the transcription factor (TF) required for Tbr1 expression is unknown, evidence
indicates that CaMKII is involved in Tbr1 upregulation. TBR1 can then induce
Grin2b expression to enhance the synaptic responses (adapted from Chuang
et al., 2014).
the cerebral cortex of Tbr1+/− mice likely exhibits defective
electrophysiological responses and thus influences behaviors,
even though anatomic defects of the cerebral cortex have not
been identified in Tbr1+/− mice. More investigations need to be
conducted to address this possibility.
ABNORMAL BRAIN WIRING AND
EXCITATION/INHIBITION
IMBALANCE—TWO PROMINENT MODELS
FOR THE PATHOGENIC MECHANISM OF
ASDs
Although the etiology of ASDs is heterogeneous, the two most
prominent models for autism pathogenesis in the literature are
abnormal brain wiring and an imbalance of neuronal activity
(excitatory/inhibitory imbalance; Rubenstein and Merzenich,
2003; Walsh et al., 2008; Bernardinelli et al., 2014; Cellot and
Cherubini, 2014; Deidda et al., 2014). These two defects lead
to abnormal information processing and result in autism-like
behaviors. These two models are interconnected to a certain
extent. During neurodevelopment, neurons must extend their
axons and form synapses with their target neurons, which allows
the activity of the downstream target neurons to be regulated.
In the absence of correct excitatory or inhibitory inputs, the
activity of target neurons will be either too low or too high.
These inappropriate levels of neuronal activity result in abnormal
information processing, which leads to aberrant behaviors.
Moreover, the imbalanced activity of neurons also influences
(either strengthens or attenuates) their connections to other
neurons. When the connection is too weak, it may be eliminated,
which may alter brain wiring. In the Tbr1+/− mouse model,
amygdalar axonal projections are defective. Both inter- and intra-
amygdalar connections are noticeably impaired. Moreover, the
NMDAR activity of amygdalar neurons is also much lower in
Tbr1+/− brains. Thus, Tbr1+/− brains are characterized by both
abnormal brain wiring and defective neuronal activation. Further
investigation is required to see whether one deficit contributes
more substantially to ASD pathology.
CONCLUDING REMARKS
Tbr1+/− mice constitute the first genetic mouse model to
show that defects in amygdalar circuits and activity result in
autism-like behaviors. TBR1 controls the expression of a panel
of genes that is associated with ASDs. TBR1 regulates axonal
growth and the neuronal activation of amygdalar neurons by
regulating downstream genes. Enhancing NMDAR activation
with D-cycloserine and clioquinol to increase neuronal activity
can ameliorate the behavioral defects of Tbr1+/− mice, although
the anatomic defects caused by Tbr1 haploinsufficiency are not
rescued. Tbr1+/− mice thereby serve as a model to elucidate how
mutation of an autism causative gene influences brain wiring
and impairs neuronal activity and consequently results in autism-
like behaviors. Nevertheless, several issues remain unresolved.
First, why is the amygdala the brain structure most sensitive
to Tbr1 haploinsufficiency? Second, since Tbr1+/− amygdalar
neurons do not correctly form inter- and intra-amygdalar
connections, a study of the mistargeting of Tbr1+/− amygdalar
axons might further illustrate the neural circuit defects caused
by Tbr1 haploinsufficiency. Third, although the anatomical
features of the cerebral cortex of Tbr1+/− mice are normal, the
electrophysiological responses of the Tbr1+/− cerebral cortex
remain to be measured. Fourth, the TBR1 downstream genes
have not been annotated in detail. Only four TBR1 direct target
genes have so far been identified. Further work is necessary to
understand the individual actions of other TBR1 downstream
target genes and how their dysfunction could generate autism-
like behaviors. Finally, it is unclear how TBR1 functions as a
transcriptional activator in some cases but acts as a repressor
in others. This phenomenon also deserves further investigation.
Addressing these questions will further elucidate the roles of
TBR1 in brains and potentially impact on autism research.
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